News
People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...
The task force determines which preventive services insurers must cover at no cost to patients.
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...
In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...
Explore more
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
The Trump administration has eliminated some grants aimed at HIV education and prevention and cut funding at the Centers for ...
In a shocking case of HIV-related stigma, a 23-year-old man was allegedly murdered by his sister and brother-in-law to ...
Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...
Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black.
Presumptive measles immunity rates were low among patients with HIV at a large US clinic, indicating targeted solutions to increase vaccine uptake are need for this at-risk population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results